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A number of inflammatory, infectious, neoplastic and idiopathic disorders affect the 
eye and the central nervous system (CNS) concurrently or at different time frames. 
These conditions pose a diagnostic challenge to the clinician since they may present 
with similar ocular and neurological manifestations. The purpose of this review is to 
describe major neurological syndromes including multiple sclerosis, Vogt-Koyanagi-
Harada disease, other autoimmune syndromes, and several infectious diseases which 
may affect the eye. This article may serve as a guide for the diagnosis and treatment 
of such disorders. It should be noted that these conditions have been viewed from 
a neurologist’s perspective thereby neurologic involvement is stressed.
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INTRODUCTION
The frequent concurrence of uveitis and 
central nervous system (CNS) diseases may 
be derived from the common embryogenic 
developmental pathway of the posterior 
segment and the CNS. Analogies between 
the blood brain barrier and the blood retinal 
barrier, and “immune privilege” involved in the 
prevention and blockage of noxious immune 
system reactions both in the eye and CNS also 
reflect the common origin of these organs. A 
North-American review1 revealed that about 
8% of individuals suffering from uveitis have 
associated neurological symptoms, however 
“neurological” patients seldom have uveitis, 
probably because neurologists usually consider 
the CNS disease as the leading condition 
requiring treatment.
Many CNS disorders affect the posterior 
segment of the eye. Despite their heterogeneous 
origin (demyelinating, infectious, inflammatory-
autoimmune and neoplastic), upon which 
the most recent classification is based, these 
diseases have a single functional unit as their 
target, represented by the CNS and the eye.
Such pathogenetic associations may underlie 
variability in prevalence related to ethnicity. 
For instance Behçet disease, which is rare in the 
USA (0.3% of uveitic entities)1, is very frequent 
in the Turkish population (more than 30%)2,3.
Apart from these considerations, we also 
have to point out that, the most represented 
patients in Smith’s work was a group of people 
suffering from CNS disease of unknown origin 
(meningitis and myelitis) or peripheral nervous 
system (PNS) disease (angiitis).1
From an etiological point of view, the two CNS Diseases and Uveitis; Allegri et al
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broadest and most recent surveys from the 
USA (1,450 patients)1 and Europe (Austria, 
1,973 subjects)4, are not univocal regarding 
the etiology of conditions described above. 
The American analysis shows that about 
8% (115/1,450 subjects) with neurological 
diseases had associated uveitis among which 
demyelinating disorders, Vogt-Koyanagi-
Harada (VKH) disease and lymphomas were 
more frequent. On the other hand, the European 
study showed that only 2.6% (52/1,973 patients) 
had a neurological/uveitis related disease, the 
most prevalent of which were demyelinating, 
VKH, bacterial, Behçet’s and lymphomatous 
disease.
This review will discuss major entities 
which present with neurological and ocular 
inflammatory diseases. 
CLASSIFICATION
The following classification is a modification 
based on the work by Brazis et al.5
Demyelinating diseases
-  Multiple sclerosis
-  Monosymptomatic optic neuritis 
Infectious diseases
-  Viral (herpes virus, cytomegalovirus, 
West Nile virus, human T-cell 
lymphotropic virus (HTLV-1), acquired 
immunodeficiency syndrome (AIDS), 
subacute sclerosing panencephalitis 
(SSPE)
-  Bacterial (cat-scratch disease, Whipple’s 
disease)
-  Mycobacterial (tuberculosis, leprosy)
-  Spirochetal (lyme, syphilis)
-  Protozoal (toxoplasmosis, pneumocystis 
carinii)
-  Nematodal or parasitic (gnathostomiasis)
Inflammatory or Autoimmune
-  Polyarteritis nodosa
-  Wegener granulomatosis
-  Rheumatoid arthritis and Sjögren’s 
syndrome
-  Systemic lupus erythematosus 
- Sarcoidosis
-  Behçet’s disease
-  VKH disease
-  APMPPE (acute posterior multifocal 
placoid pigment epitheliopathy)
Neoplastic
- Lymphoma
-  Paraneoplastic syndromes 
DEMYELINATING DISEASES
Multiple sclerosis (MS) may affect the 
entire CNS and must be distinguished from 
monosymptomatic optic neuritis (MSON) 
which presents with ocular symptoms but 
no systemic involvement. MSON can cause a 
single episode, or lead to multiple recurrences 
of ocular involvement. A number of patients, 
after some years of quiescence, evolve to MS 
such that 40% of MSON cases develop MS in 
8 to 10 years (Fig. 1A).
Isolated or combined with other neurological 
symptoms, optic neuritis mainly affects young 
patients (less than 30 years of age) and is rarely 
seen after the age of 45. In the latter case, the 
disease presents with medullary deficits and 
a rapidly disabling course. Based on such 
multiform clinical findings, one may assume 
that MS is not a single clinical entity, but a 
group of demyelinating diseases which can be 
differentiated from each other not only on the 
basis of symptoms and course, but also according 
to etiology, genetics, immunopathogensis and 
response to therapy. 
Figure 1A. Monosymptomatic optic neuritis (MSON). 
Top right shows an MRI image of a demyelinating plaque 
of the right optic nerve with corresponding visual field 
changes (bottom right). Retinal vasculitis is well evident 
on fluorescein angiography (left frames, arrows).CNS Diseases and Uveitis; Allegri et al
286 JOURNAL OF OPHTHALMIC AND VISION RESEARCH 2011; Vol. 6, No. 4
Optic neuritis usually presents with acute 
unilateral blurring of vision, transient photopsia, 
ocular or orbital pain (due to optic nerve edema) 
and other neurological complaints including 
sensory, motor, cerebellar and urinary bladder 
symptoms. Other symptoms such as diplopia, 
vertigo (due to proximity of the oculomotor 
area to the equilibrium area), trigeminal 
neuralgia, neuro-vegetative deficits (mainly 
orthostatic hypotension) and cognitive deficits 
are infrequent.
The course of MS is characterized by 
relapses and remissions (more commonly during 
the early stages of the disease) but may occur 
as a primary or secondary chronic-progressive 
disease. In later stages, a number of variations 
and mixed forms such as chronic-progressive 
disease with overlapping relapses are possible.
Magnetic resonance imaging (MRI) shows 
hyperintense round/oval demyelinating lesions 
mainly in periventricular areas on T2-weighted 
sequences (Fig. 1B). If the same lesions appear 
hypointense on T1-sequences, axonal damage 
may accompany the demyelinating lesion 
(Figures 2A and 2B).
A classic acute attack of MS or MSON 
usually lasts more than 24 hours; if visual 
or non-visual symptoms are transient, they 
represent only brief deterioration due to CNS 
causes leading to nerve conduction delay. In 
these cases symptoms rapidly disappear when 
the exciting cause subsides.
Intermediate uveitis is associated with MS; 
10-20% of uveitic subjects show MS symptoms 
after some years, and a similar number of MS 
cases present with major anatomo-pathological 
signs of intermediate uveitis. These may 
include retinal peri-vasculitis mainly affecting 
veins in the active phase, vascular sheathing 
in the chronic phase, and perivenous sclerosis 
following retinal vasculitis in over 30% of 
chronic-progressive MS patients (Fig. 1A, left 
frames). Retinal vein inflammation is directly 
related to activity of the systemic disease and 
portends an unfavourable prognosis. This 
typical association between retinal vasculitis 
and MS finds its anatomical explanation in 
the common origin of the blood brain and 
blood retinal barriers, and their inflammatory 
breakdown.
Another inflammatory ocular association 
of MS is recurrent granulomatous or non-
granulomatous acute anterior uveitis which 
usually presents bilaterally but asymmetrically.
The genotypic prevalence of MS associated-
uveitis was recently investigated in a study 
which found a high predominance of HLA-DR15 
and DR2 genotypes.6 HLA associations identify 
subjects at risk of developing the disease but 
they are not diagnostic markers. With the 
exception of age, no significant differences have 
been observed in patients with and without 
associated MS.
Figure 1B. Brain MRI in multiple sclerosis shows 
multiple lesions (hyper-intense on T2-weighted images) 
located in the white matter of both hemispheres.
Figure 2 (A-B): MRI in multiple sclerosis: a hyperintense 
parietal white matter lesion on T2 (A), appears 
hypointense on T1 images (B).
A BCNS Diseases and Uveitis; Allegri et al
287 JOURNAL OF OPHTHALMIC AND VISION RESEARCH 2011; Vol. 6, No. 4
INFECTIOUS DISEASES
Herpes Virus Infections
Herpetic infections, including herpes simplex 
virus (HSV) types 1 and 2, varicella zoster virus 
(VZV), cytomegalovirus (CMV), and Ebstein-
Barr virus (EBV), are diseases that typically affect 
immunocompromised, HIV-positive, atopic, or 
transplanted individuals or patients receiving 
cytostatic, steroid or immune-suppressive 
therapy. However, an increasing incidence is 
noted nowadays in healthy people. The status of 
the host’s immune system defines the outcome 
of these infections and complications related 
to these viral entities.
Ocular involvement presents in two 
major forms: 1) anterior uveitis and 2) viral 
retinopathies.8 Viral retinal involvement is 
subdivided into different clinical entities, 
namely: necrotizing retinopathy including acute 
retinal necrosis (ARN) and progressive outer 
retinal necrosis (PORN), and non-necrotizing 
herpetic retinopathy (NNHR), that affects 
subjects under corticosteroid therapy for 
autoimmune diseases such as Behçet’s disease.
ARN is usually caused by VZV and 
HSV, but more rarely by CMV9,10 and is 
typically unilateral. It affects both healthy 
and immunocompromised patients and is 
characterized by acute necrotizing retinitis 
with retinal arteriolitis, optic neuritis and 
severe vitritis.7 PORN is frequently bilateral, 
affects immunocompromised subjects and is 
characterized by mild anterior uveitis without 
vitritis and an acute necrotizing retinitis 
beginning in the posterior pole extending toward 
the retinal periphery.11 NNHR presents as 
bilateral chronic and atypical posterior uveitis.12
All herpetic infections show tropism 
for sensory ganglia inside which the virus 
remains dormant during periods of latency. 
This mechanism explains how herpes viruses 
spread to ganglia-derived areas (dermatomes).
Neurological manifestations are usually 
not related to immune system dysregulation 
or suppression. HSV neurological infections 
cause: 1) encephalitis and 2) recurrent aseptic 
meningitis.
Encephalitis is mainly related to 
reinfection or reactivation of HSV type 1 
in immunocompetent subjects; HSV type 2 
primary infections affect immunocompromised 
patients and re-infections are rare (4-6%). 
Necrotizing acute encephalitis is frequently 
localized to the temporal lobes, sometimes 
with meningeal involvement, and presents 
with typical symptoms of meningoencephalitis 
(high fever, headache, sensory abnormalities), 
associated with memory, personality and 
speech disturbances because of hippocampal, 
frontal and temporal lobe lesions respectively 
(Fig. 2C).13,14
VZV infection typically presents with 
sensory ganglia involvement including thoracic 
or cranial (mainly ophthalmic division of 
trigeminal nerve) ganglia with dermatomal 
cutaneous manifestations. In the central 
nervous system, VZV produces herpes zoster 
ophthalmicus which can involve the eye where 
it produces anterior granulomatous uveitis often 
resulting in sectorial iris atrophy. Although 
herpes zoster is due to reactivation of dormant 
varicella virus, it is an acute viral infection 
that requires prompt treatment with systemic 
antivirals to avoid complications which occurred 
in the era before antivirals were available.15
VZV encephalitis and other viral CNS 
Figure 2C. Herpes encephalitis, MRI section shows 
bilateral hyperdense lesions in the temporal and parietal 
lobes.CNS Diseases and Uveitis; Allegri et al
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inflammations are less frequent than HSV 
infections.
Apart from these classical forms, a new 
neurological entity called “Zoster sine herpete” 
has been described, thanks to the recent 
introduction of polymerase chain reaction 
(PCR) tests. It presents as aseptic meningitis 
or encephalitis (with cerebellar tropism), 
sometimes as transverse myelitis, or cerebral 
vasculopathy derived from granulomatous 
angiitis (late CNS vasculitis) with deep ischemia 
of the basal ganglia, temporal lobes, and the 
internal capsule.9
Primary herpetic infection results in 
axoplasmic transport of the virus to sensory 
ganglia where it establishes latency. Reactivation 
leads to retrograde virus transport. The true 
path by which the virus reaches the CNS has 
not been established, one possibility is that 
the reactivated virus located in ganglia may 
spread to the anterior and middle cranial fossa. 
The mechanism by which herpes viruses 
affect the eye is the double occurrence of a lytic 
reaction followed by intraocular inflammation.12
History and clinical examination of herpetic 
infections of the CNS and eye are usually 
diagnostic because they are well-defined entities. 
In controversial or atypical presentations, 
molecular diagnosis of cerebrospinal or ocular 
fluids by PCR provides high sensitivity (96%) 
and specificity (99%)10,12 for detection of herpetic 
DNA.
For diagnostic purposes in equivocal 
cases of meningoencephalitis, the following 
techniques may be useful: 1) cerebrospinal 
fluid (CSF) analysis revealing typical features 
of monocytic pleocytosis, high protein content 
and normal glucose content; 2) neuro-imaging 
studies including computed tomography (CT) 
or ideally MRI with characteristic findings of 
symmetric necrosis of the temporal lobes; 3) 
electroencephalography typically showing 
periodic spike waves on temporal derivations. 
These investigations may facilitate diagnosis 
leading to prompt and specific therapy with 
systemic antiviral agents, preventing severe 
ocular and neurological sequelae and sometimes 
death.13 
Recurrent aseptic meningitis is mainly 
due to HSV 2; history is positive for herpes 
genitalis and this infection seems to spread 
via the oculogenital route to the eye and via 
sacral sensory ganglia to the CNS. It presents 
with symptomatic meningitis and fever, 
meningism, an intense headache lasting for 
some days followed by alternating recovery 
with symptomatic periods. Typical CSF findings 
are lymphocytic pleocytosis and high protein 
levels. PCR investigation is almost always 
positive; viral culture is positive only in the 
early stages of the disease.
CNS and ocular infections due to CMV have 
been reported following congenital infections 
and in patients with AIDS in the pre-HAART 
(highly active anti-retroviral therapy) era due 
to severe immunodeficiency, sometimes causing 
death. Currently, the course of CMV retinitis or 
meningoencephalitis in immunocompromised 
hosts has dramatically changed and CMV 
infection may present as the first and only 
clinical manifestation of AIDS.
CMV infection in the eye presents as active 
retinitis with a typical “pizza-like” appearance 
consisting of white-yellowish cotton wool 
areas of necrotizing retinitis associated with 
hemorrhage and vascular sheathing with mild 
vitritis evolving towards progression of retinitis 
and retinal scarring. Disk atrophy follows 
papillitis or acute anterior optic neuritis in the 
acute phase 16.
CMV encephalic infection is mainly localized 
to the brainstem (similar to Behçet’s disease). 
Typical symptoms are lid ptosis, oculomotor 
disturbances and nystagmus. Ventriculitis and 
inflammatory poly-neuropathies are infrequent.
Bell’s palsy may be caused by any of the 
viral diseases under this category; however, 
to date, there has been no association with 
uveitic entities. 
Human T-cell Lymphotropic Virus Type 1
HTLV-1 is the cause of T-cell leukemia and 
of a peculiar myelopathy (tropical spastic 
paraparesis) which may be associated with ocular 
manifestations including keratoconjunctivitis 
sicca, corneal lesions, retinal vasculitis and 
uveitis, otherwise known as HTLV-1 associated CNS Diseases and Uveitis; Allegri et al
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uveitis or HAU. It is more frequent in Japanese, 
African, Caribbean and South-American 
patients.17 Transmission occurs through sexual 
contact, needle injection or sharing, and also 
vertically from mother to child.
AIDS
Indirect AIDS consequences are opportunistic 
infections and tumors. HIV-1 viral infection 
can directly induce a number of neurological 
syndromes18 which can present as an acute 
disease (aseptic acute meningitis and 
meningoencephalitis) or as a chronic disorder 
(HIV encephalopathy, AIDS-dementia complex). 
These conditions are difficult to diagnose 
because of the very slow progression of cognitive 
and behavioral impairment which can be 
misdiagnosed as reactive neuropsychological 
symptoms. MRI usually shows cortical and 
subcortical atrophy and T2 hyperintense areas 
related to demyelinization.
Ocular manifestations of AIDS can be 
categorized into four main groups19: micro-
angiopathy manifesting as cotton wool spots 
and vascular occlusions; opportunistic infections 
including CMV, herpetic, toxoplasmic, fungal 
and parasitic retinitis; neoplasms such as 
lymphomas and skin carcinomas particularly 
Kaposi sarcoma; and neuro-ophthalmic 
presentations including papilledema, papillitis, 
visual field defects and oculomotor palsies.
West Nile Virus 
West Nile virus (WNV) infection is a mosquito-
borne disease widely distributed in all 
continents. Since 1999, when the first outbreak 
of WNV encephalitis occurred in New York city, 
it has had an impressive spread, representing a 
recent example of geographical evolution of a 
disease formerly restricted to specific areas.20
WNV, similar to other arbovirus (flavivirus 
family) transmitted infections such as dengue, 
yellow fever and Japanese encephalitis, shares 
the common feature of neuro-invasiveness with 
grey matter affinity, with loci of involvement in 
the cortex, basal ganglia, brainstem, cerebellum 
and spinal cord. Less than 1% of infected 
individuals develop severe neuro-invasive 
diseases which can be classified into three 
major but sometimes overlapping, clinical 
syndromes: meningitis, encephalitis and acute 
flaccid paralysis.21
Meningitis has the usual manifestations: 
fever, headache and neck stiffness. Encephalitis 
shows focal symptoms related to the site of 
involvement such as epilepsy (cortex), tremor 
and involuntary movements (basal ganglia), 
parkinsonism (substantia nigra) and ataxia 
(cerebellum). Encephalitis incurs severe sequelae 
and a high incidence of death. Acute asymmetric 
flaccid paralysis, similar to poliomyelitis (a 
selective lesion in anterior spinal horns), has an 
unfavourable outcome with variable recovery.
Before the onset of ocular or CNS 
symptoms, many patients are healthy without 
any signs of immunosuppression, while some 
(approximately 20%) complain of mild flu-like 
symptoms including headache, fever, malaise, 
gastrointestinal upset, skin rash, neck rigidity 
and changes in mental status. 
Ocular manifestations are uncommon 
although chorioretinitis may be more frequent 
than previously reported.22 Bilateral multifocal 
chorioretinitis with typical clinical and 
fluorescein angiographic features including 
linear clusters of oval chorioretinal lesions 
primarily located in the posterior pole or in 
the mid-periphery along major retinal vessels, 
is the most common finding followed by other 
ophthalmic manifestations such as anterior 
uveitis, vitritis, retinal vasculitis, and optic 
nerve involvement (optic neuritis and optic 
disc swelling).
Detection of WNV–specific IgM in the 
serum or CSF provides strong evidence of recent 
infection. IgM usually becomes detectable 8 
days after the onset but may become elevated 
after some months22. Therefore, WNV-IgM may 
reflect previous infection rather than recent 
disease. Direct detection of WNV in the CSF, 
serum or tissue specimens by viral isolation 
is also of possible diagnostic value. Patients 
with neuro-invasive disease show lymphocytic 
pleocytosis in the CSF. MRI is usually normal, 
but signal modifications may be seen in the 
basal ganglia, thalamus, brainstem and anterior CNS Diseases and Uveitis; Allegri et al
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spinal cord of patients with encephalitis or 
acute flaccid paralysis.
Subacute Sclerosing Panencephalitis
Subacute sclerosing panencephalitis (SSPE) is 
an encephalopathy of subacute course affecting 
children and adolescents caused by an aberrant 
measles virus called the SSPE virus. It is 
characterized by progressive encephalopathy 
involving both grey and white matters with a 
fatal outcome in most cases.23
Ocular involvement is seen in more than 
half of the cases and is usually bilateral. The 
macular area is usually involved by retinitis or 
pigmentary changes. Optic neuritis is present 
in two-thirds of cases with ocular involvement. 
Ocular findings may sometimes precede CNS 
signs and symptoms. Macular involvement may 
resemble acute posterior multifocal placoid 
pigment epitheliopathy (APMPPE) which is 
one of the differential diagnoses.24
Syphilis
Ocular involvement in subjects affected 
with syphilis is strongly suggestive of CNS 
involvement and should be considered 
synonymous with neuro-syphilis.25 Neuro-
syphilis has protean clinical patterns26 including 
early or secondary syphilis (asymptomatic 
neurological, meningeal and meningovascular 
involvement), and late or tertiary syphilis 
(progressive general paralysis and tabes 
dorsalis). Antibiotic treatment reduced the 
prevalence of the disease in the years following 
World War II but nowadays, a rising incidence 
is being observed due to immigration waves 
and changes in sexual habits.
From an ophthalmological point of view,27 
secondary syphilis may cause: 1) cranial mono-
neuropathies, i.e. oculomotor nerve palsies, 
due to vasa nervorum vasculitis, meningeal 
inflammatory reaction, intracranial pressure 
increase or gumma production; 2) optic neuritis 
and perineuritis related to meningitis; 3) Argyll-
Robertson pupil due to lamina quadrigemina 
infectious involvement.
Acute meningitis can occur in 1 to 2% of 
patients with secondary syphilis, and can cause 
papilledema due to a rise in intracranial pressure. 
With papillitis and vitritis, patients complain 
of acute visual loss; neuroretinitis manifests 
with hard exudates in the peripapillary area. 
Another manifestation is optic “perineuritis” 
which may be suspected in a subject with optic 
nerve head swelling without ocular symptoms 
which is due to mild inflammation of meningeal 
sheaths of the optic nerve. Many patients with 
ocular signs do not show systemic evidence of 
the syphilitic disease. 
Ocular manifestations also include anterior 
(granulomatous and non-granulomatous) 
uveitis, intermediate uveitis, panuveitis, 
chorioretinitis, retinal vasculitis, and necrotizing 
retinitis; the latter may be the first presentation 
in patients with HIV infection. Ocular syphilis 
has to be treated exactly in the same way as 
neuro-syphilis. 
Tertiary syphilis may present with 
meningovascular and late parenchymal 
consequences and from an ophthalmological 
point of view, with interstitial keratitis or 
different forms of uveitis. The slower and 
more chronic course of tertiary syphilis is the 
only difference between secondary and tertiary 
stages of the disease. A small number (5%) of 
tertiary neuro-syphilis patients suffer from 
optic atrophy.
The protean expressions of syphilis, 
particularly ocular involvement, have caused 
the disease to be designated as “the great 
imitator”.
Lyme Disease
Lyme disease is a tick-borne infection due to 
different types of Borreliae, called “the new great 
imitator” since it displays a broad variety of 
systemic symptoms ranging from skin erythema 
migrans to neurologic or cardiac lesions. Ocular 
manifestations28 usually appear in late stages 
of the disease. Early manifestations of the 
disease may include transient conjunctivitis and 
episcleritis; they may reappear in late stages 
which are typically characterized by interstitial 
keratitis, uveitis (anterior, intermediate, 
posterior and panuveitis), choroiditis and CNS Diseases and Uveitis; Allegri et al
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retinal vasculitis.
Neuro-ophthalmic manifestations29, in 
contrast to ocular signs, appear at an earlier 
stage (in the second or dissemination phase). 
Borreliae pass the blood brain barrier in the 
first weeks of the infection, and may lead 
to symptoms of cranial and spinal nerve 
involvement (with facial nerve neuropathy being 
the most common neuropathy, comprising 50% 
of all neurologic symptoms of Lyme disease). 
Optic nerve involvement (neuritis, papilledema, 
neuroretinitis) can also occur during this stage 
(Fig. 3).
Cranial neuropathies may result from 
direct infection, autoimmune inflammatory 
response (i.e. vasculitis of vasa nervorum), 
or raised intracranial pressure. Trigeminal 
nerve involvement may present as bilateral 
decrease in corneal sensation or as ocular and 
periocular pain. Papilledema may occur with 
meningitis and increased intracranial pressure. 
Horner’s syndrome, tonic or dilated pupils, 
and photophobia have also been described as 
signs of encephalopathy or meningitis.
In the third stage, circumscribed vasculitic 
brain lesions appear and result in different 
symptoms according to the site of involvement 
(dementia, ataxia and spastic paraparesis) and 
an MRI pattern similar to that of MS (multiple 
hyperintense white matter lesions on T2 weighted 
images). In demyelinating disease, involvement 
of basal ganglia grey matter is absent.29,30
Serological tests for Borrelia lack adequate 
sensitivity and specificity, but PCR may be a 
useful diagnostic tool. Early antibiotic therapy 
is the mainstay of management; steroids can 
be added in subjects with severe intraocular 
or encephalic inflammation.
Toxoplasmosis
Neuro-toxoplasmosis is the major cause 
of encephalitis and retinitis in immuno-
compromised hosts occurring in 1-3% of 
patients. One third of AIDS patients suffer 
from this disease (Figures 4A, 4B, 5A and 5B). 
Papilledema is also seen in affected eyes.
From a neurological point of view, lesions 
may be localized to the basal ganglia, causing 
symptoms such as involuntary movements31 
or in cerebral hemispheres with a predilection 
for the occipital lobes producing typical visual 
field defects. Fever, headache, seizures, and 
sensory deficits are accompanying features of 
these symptoms.
Major ocular lesions32 in immuno- 
compromised patients are foci of necrotizing 
retinitis presenting as large bilateral multifocal 
areas of retinitis which are also typical of 
congenital infection (Fig. 5C). 
Immunocompetent individuals show small 
and isolated lesions of necrotizing retinitis 
without CNS involvement. These acute lesions 
appear as white foci of retinitis with poorly 
defined margins healing as a pigmented and 
atrophic scar. Chorioretinal toxoplasmic lesions 
are self-limiting only in immunocompetent 
individuals.
Figure 3. Lyme disease: MRI appearance of right optic 
nerve enhancement after administration of paramagnetic 
contrast (T1-weighted image).
Figure 4 (A and B). AIDS-related neuro-toxoplasmosis: 
CT scan of a toxoplasmic localization in the right 
capsulonuclear region with wide peri-lesional edema 
before (A) and after (B) contrast injection.
A BCNS Diseases and Uveitis; Allegri et al
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Diagnosis is mainly clinical although 
serological investigations including PCR and 
local antibody production detection are helpful 
in atypical cases.
In immunocompetent patients, anti-
toxoplasmic therapy is only useful in terms 
of reducing the rate of recurrence, but does 
not seem to be effective in the acute stage. 
Such therapy, in vision threatening disease, 
may be strengthened by systemic steroid 
administration which is useful in controlling 
the inflammatory reaction and accelerating 
recovery. Anti-toxoplasmic antibiotic therapy 
is useful in immunosuppressed patients, but 
corticosteroids are not required in severely 
immunocompromised patients.
Whipple’s Disease
Whipple’s disease (WD) is a multi-systemic 
infection with predominantly gastrointestinal 
manifestations caused by an actinomyces 
(Tropheryma Whippelii). Major presenting 
symptoms include diarrhea, impaired intestinal 
absorption and progressive weight loss. Once 
the organism enters the bloodstream via the 
intestinal lamina propria, ‘colonization’ of 
the CNS occurs in a variable number of cases 
(43-100%) according to differing studies. 
Asymptomatic phases alternate with sudden 
relapses, suggesting direct action of the 
microorganism27. Neurologic symptoms are 
due to involvement of cerebral hemispheres 
(dementia, myoclonus, and epilepsy), 
hypothalamus (insomnia, hyperphagia, 
polydipsia) and brainstem (nystagmus, supra-
nuclear ophthalmoplegia, diplopia and lid 
ptosis). The rare but pathognomonic sign is 
ophthalmo-masticatory myorhythmia, which 
consists of abnormalities of vertical eye 
movements with pendular nystagmus associated 
with tongue and mandibular movements. The 
most common symptoms are dementia, which 
may be reversible, followed by supranuclear 
ophthalmoplegia, myoclonus and hypothalamic 
disorders. 
Ocular manifestations are secondary to CNS 
involvement. According to a large review33,34, 
WD ocular involvement appears to be present 
in about 4% of all cases, with a variety of 
manifestations including anterior uveitis, 
vitritis, retinal vasculitis, chorio-retinitis, optic 
disc edema and optic atrophy.
Cat Scratch Disease
Cat scratch disease is a systemic zoonosis 
caused by a gram-negative bacillus (Bartonella 
henselae). Systemic infection after primary 
inoculation is associated with localized 
erythema and regional lymphadenitis with 
flu-like symptoms.
The major neurological manifestation 
(in 1-2% of cases) is encephalopathy from 
infective micro-localizations, involving 
both hemispheres and underlying cerebral 
Figure 5C. Toxoplasmic retinitis in a patient with AIDS, 
note the absence of inflammatory reaction.
Figure 5 (A and B). AIDS-related neuro-toxoplasmosis: 
single toxoplasmic lesion in the left frontal lobe (T2-
weighted sequence, A), which shows ring-shaped 
enhancement after contrast injection (T1-weighted 
sequence, B).
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structures. Characteristic symptoms are epileptic 
seizures29 and personality disorders (especially 
aggressiveness) due to cerebral lesions, and 
lethargy caused by brainstem localization. Less 
frequent signs are cranial (especially facial) 
neuropathies.
The largest reported case series35 included 
76 patients, 61 with encephalopathy and 15 
with cranial neuropathies.
When the eye is involved, the disease is 
characterized by Parinaud’s oculoglandular 
syndrome including red eye, mucoid conjunctival 
exudates and unilateral lymphadenopathy. 
After hematogenous spread neuroretinitis, 
chorioretinal lesions (typically juxtavascular), 
and sometimes capillary angiomatous 
proliferation may be noted.35,37
Gnathostomiasis
Gnathostomiasis is a parasitosis due to 
nematodes of the genus Gnathostoma (mostly 
G. spinigerum, sometimes G. hispidum), 
which is endemic in subtropical Asia (from 
Thailand to Japan) and in some parts of the 
American continent (especially in Mexico). 
In the “visceral” stage of its complicated life 
cycle which follows the “cutaneous” stage, 
this parasite can involve all internal organs, 
including the eye and CNS. Neurological 
manifestations are associated with a high 
percentage of mortality and include (in order 
of appearance): radiculo-myelitis, radiculo-
myelo-encephalitis, eosinophilic meningitis and 
subarachnoidal hemorrhage (SAH). Parasites 
enter the CNS through nerve roots (both spinal 
and cranial) and give rise to symptoms (e.g. 
radicular pain), which persist for some days. 
Afterwards, limb paralysis (from a single to 
all four limbs, mostly paraplegia) can occur 
when parasites ascend to the brain. Finally, 
eosinophilic meningitis and SAH, the most 
frequent causes of death, ensue. In Thailand, 
6% of all SAH in adults and 18% of SAH in 
children appear to be due to gnathostomiasis.
The eye is the only organ where gnathostoma 
can be visualized, usually in the anterior 
chamber, but also rarely in the vitreous. Ocular 
symptoms include uveitis (mostly anterior), 
iritis, intraocular hemorrhage, glaucoma, retinal 
scarring and retinal detachment. 
Because of the “immune privilege” status of 
the eye, eosinophilia is less marked with ocular 
disease than when other organs are involved.38
OTHER INFECTIOUS DISEASES 
Anterior uveitis can occur in meningococcal 
sepsis, a potentially fatal illness and less 
frequently with meningococcal meningitis.
The most frequent neurological manifestation 
of tuberculosis is meningitis, which unlike other 
causes of bacterial meningitis is characterized 
by clear CSF with monocytic pleocytosis due 
to rupture of sub-ependymal tubercles. Intra-
parenchymal granulomas can induce epilepsy. 
Other symptoms of neuro-tuberculosis are 
papilledema, retrobulbar optic neuritis and 
oculomotor nerve palsy. Ocular involvement is 
polymorphic and any form of uveitis is possible, 
the most common being posterior uveitis, 
serpiginous-like choroiditis and subretinal 
abscesses due to foci of caseous necrosis.
Mycoplasma pneumoniae infection can 
cause aseptic meningitis. Symptoms related to 
involvement of the left hemisphere, i.e. right 
hemiparesis and motor aphasia, have been 
described by Perez and Foster15 as well as sixth 
and seventh cranial nerve palsy. The eye may 
be affected with mild anterior uveitis.
Neurological involvement in cryptococcosis 
includes meningitis (presenting with nausea, 
drowsiness, irritability, headache and neck 
stiffness), peri-optic meningeal infiltration 
leading to retrobulbar optic neuritis and 
cranial nerve (mostly sixth nerve) palsy, and 
parenchymal localization causing dementia. In 
40% of cases of neuro-cryptococcosis, ocular 
involvement is present, mostly as multifocal 
chorioretinitis.18
Leptospirosis has an initial phase of blood 
diffusion and a second “immune phase” due to 
circulating antibodies, which in 50% of cases 
includes aseptic meningitis with monocytic 
pleocytosis and cranial nerve palsies. At the 
same time, acute anterior uveitis with fine 
keratic precipitates and posterior synechiae can 
occur. Cataract development is also a frequent CNS Diseases and Uveitis; Allegri et al
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complication.
Leprosy affects the peripheral nervous 
system causing mainly sensory poly-neuropathy 
with neuropathic pain and paresthesia in the 
first stage, and sensory loss with susceptibility 
to traumatic limb injuries in more advanced 
stages. Acute or chronic anterior uveitis may 
be present in 10-50% of cases.18,19 
OCULO-CEREBRAL VASCULITIS 
Cerebral vasculitides (CVs) are associated 
with retinal vasculitis and uveitis in different 
percentages. CVs are present in a number of 
systemic autoimmune disorders and show 
common clinical aspects: 1) a symptomatic 
pattern including headaches (due to stimulation 
of perivasal nervous endings), multifocal 
deficits (secondary to ischemic lesions) and 
neuropsychiatric symptoms (due to ischemic 
lesions or, as in SLE, related to auto-antibodies); 
2) blood signs of acute inflammation; 3) co-
existence of central and peripheral neurological 
deficits (e.g. mononeuritis multiplex, similar to 
vasa nervorum vasculitis); 4) frequent extra-
neurological involvement, because vasculitides 
are systemic diseases. 
On MRI vasculitic lesions are usually 
hyperintense on T2- but sometimes also on T1-
weighted sequences (Figures 6A and 6B). If an 
isolated CV presents, CSF analysis is essential 
but for a definite diagnosis, a cerebral biopsy 
may be necessary.
CVs which commonly affect the eye include 
polyarteritis nodosa, Wegener’s granulomatosis, 
rheumatoid arthritis (more often, Sjögren’s 
syndrome) and systemic lupus erythematosus.
Polyarteritis nodosa (PAN) is a necrotizing 
segmental inflammation of small and middle 
sized arteries; it is frequently (70%) associated 
with hepatitis B virus (HBV) seropositivity and 
clinically presents as peripheral involvement 
(mononeuritis multiplex in 70% of cases) 
as compared to CNS lesions (ischemic or 
hemorrhagic stroke in 10%). Vasculitic 
involvement can affect all ocular structures 
leading to episcleritis, diffuse/nodular scleritis, 
vasculitic or occlusive retinopathy, choroidal 
vasculitis (the most frequent manifestation), 
ischemic optic neuropathy and orbital 
vasculitis (with extraocular muscle ischemia 
and amaurosis fugax).39
Wegener’s granulomatosis (WG), together 
with Churg-Strauss arteritis and microscopic 
polyangiitis, is one of the ANCA (anti-
neutrophil cytoplasmic antibody)-positive 
Figure 6. MRI in disseminated CNS vasculitis (T2-
hyperintense lesions) with localizations, in the same 
patient, both in the central pontine area (A) and in the 
cervical cord (B).
A
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vasculitides. Neurological manifestations are 
caused by invasion from paranasal sinuses to 
the cranial nerves causing oculomotor nerve 
deficits40, to the hypothalamus leading to 
diabetes insipidus, and to the meninges with 
aseptic meningitis (Figures 7A-C). Angiitis with 
lymphoreticular infiltrates and necrosis can 
produce direct vascular lesions: e.g. ischemic 
optic neuropathy, or ischemic cerebral lesions 
with focal symptoms (strokes, seizures). As 
with all systemic diseases, WG can also affect 
all ocular structures including the choroid, but 
with a predilection (in contrast to PAN) for the 
anterior segment and orbit.
Rheumatoid arthritis (RA) can be the 
cause of central or, more frequently peripheral 
(vasa nervorum) vasculitic involvement; 
however, retinal vasculitis is rare. Sjögren’s 
syndrome, an independent or RA-linked 
disease which was once thought to be a 
variant of RA, presents with frequent, both 
central and peripheral neurological symptoms 
which precede the diagnosis of the condition 
in most cases.41 Ischemic CNS lesions, both 
supra-spinal and spinal, are present.42 Supra-
spinal lesions cause optic neuritis (in more 
than 20% of cases with CNS involvement), 
cognitive impairment, and epilepsy. Spinal 
lesions produce acute or chronic myelopathy. 
Sjögren’s syndrome mimics the clinical course 
of MS at the central level and in the neuro-
radiological pattern. Peripheral involvement 
generates any type of neuropathy due to vasa 
nervorum vasculitis.42 The most common 
and typical form is a predominantly sensory 
polyneuropathy. Autonomic neuropathy, with 
orthostatic hypotension and Adie’s pupil, is 
less frequent. Biopsy shows a typical pattern 
of axonal neuropathy (as a rule in ischemic 
neuropathies), with axonal loss, angiitis and 
perivascular infiltrates.
Systemic lupus erythematosus (SLE), one 
of the most polymorphous diseases, can cause 
neurological manifestations with different 
mechanisms. Focal symptoms (epileptic seizures, 
motor and sensory deficits, extra-pyramidal 
symptoms) are due to circumscribed lesions of 
vasculitic nature (Fig. 8). At onset, thrombotic 
vasculopathy, immune complex vasculitis, 
Figure 7. Wegener’s granulomatosis (CT scan 
without contrast): the maxillary sinuses are filled 
with granulomatous tissue (A); the same lesions, after 
treatment, show reduction in granulomatous invasion 
(B); perforation of the nasal septum (C).
A
C
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anti-phospholipid antibody syndrome, or 
embolization from Libman-Sacks endocarditis 
can be present. SLE has an apparent tropism 
for the vertebrobasilar system, with a high 
frequency of brainstem symptoms (transient 
diplopia, vertigo, internuclear ophthalmoplegia) 
and for the occipital lobes (visual hallucinations, 
hemianopsia, geniculo-calcarine blindness). 
Also, headaches frequently have a vasculitic 
origin.
Neuropsychiatric disorders (depression, 
psychosis) are caused by direct action of 
anti-neuron antibodies including anti-P (anti-
ribosomal P-protein) and anti-N (anti-neuronal 
cell) antibodies.43
As in PAN and WG, any ocular structure 
can be affected, from the lacrimal system 
to the retina. Inflammatory arteriolar 
vasculopathy is more severe in the presence 
of anti-cardiolipin antibodies and is often 
complicated by proliferative retinopathy in the 
case of major vascular occlusion, by pigmentary 
alterations (“pseudoretinitis pigmentosa”), or 
by exudative retinal detachment (secondary to 
choroiditis) although less common than retinal 
involvement.44
SARCOIDOSIS 
Sarcoidosis is a protean multisystemic disease 
of unknown origin caused by dysfunctional 
T-lymphocytes, phagocytes, and epithelioid 
cells generating non-caseating granulomatous 
multi-organ inflammation. Neurological 
and ocular manifestations of sarcoidosis are 
uncommon and present in 5 to 10% of cases 
according to different reports. No predisposing 
factors are evident. Neuro-sarcoidosis (NS) 
begins in the leptomeninges and spreads 
through the subarachnoid space to other 
meningeal structures, the hypothalamus, 
hypophysis, chiasma and cranial nerves, and 
through perivascular areas towards encephalic 
parenchyma. Infrequently, encephalic vasculitis 
may be present.
Meningeal localization is evident in more 
than 90% of autopsies but clinical manifestations 
of such involvement are less frequent (8-64%).45 
A recent neuro-imaging survey45 showed 
that only 1/3 of affected patients were MRI-
gadolinium enhanced positive for meningeal 
involvement.
According to different studies,45-48 neuro-
logical symptoms have discordant incidences 
and are classified as:
a)   Optic neuritis (present in 8-13% of 
symptomatic patients) is caused by 
granulomatous optic nerve infiltration, 
intracranial hypertension following 
meningitis, extrinsic compression, and vasa 
nervorum vasculitis. Related symptoms 
are pupillary abnormalities (tonic pupils) 
and hemianopsia (occipital visual pathway 
involvement).
b)   Single or multiple cranial nerve involvement 
caused by nerve infiltration, vasa nervorum 
vasculitis, intracranial hypertension or 
compression. The seventh cranial nerve is 
mainly involved (20-50%) because of parotid 
compression, followed by oculomotor 
manifestations (diplopia), the so-called 
Parinaud’s syndrome.
c)   Peripheral nerve sensory-motor neuropathy.
d)   Cerebral localization (generalized seizures 
and psychiatric symptoms).
e)   Granulomatous infiltration myopathy.
Figure 8.  CNS vasculitis in lupus: spontaneous T1-
hyperintense lesions in the right striatum.CNS Diseases and Uveitis; Allegri et al
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f)   Neuroendocrine symptoms (15-23%) 
including hypogonadism and diabetes 
insipidus because of granulomatous 
involvement of the hypothalamus and 
hypophysis.
Polymorphic ocular manifestations of 
sarcoidosis may coexist; these include adnexal 
involvement (lacrimal glands, extraocular 
muscles, lid granulomas), conjunctivitis, 
episcleritis, scleritis, keratitis, granulomatous 
or non-granulomatous anterior uveitis, 
posterior uveitis (subretinal granulomas, retinal 
vasculitis), optic nerve involvement (granulomas 
of the optic disc, papillitis, papilledema). Uveitis 
is the most frequent sign in NS48 and anterior 
uveitis is present in 1/3 of subjects.
Ocular manifestations in subjects suffering 
from NS are more common than previously 
thought. Patients with neurological symptoms 
and associated intraocular inflammation should 
undergo work-up for sarcoidosis including brain 
and orbital MRI (Figures 9 and 10) and lumbar 
puncture; tissue biopsy should be performed 
if there are clinically accessible lesions.
Oral steroids are the mainstay of treatment 
for NS and associated intraocular involvement; 
when they fail, systemic immunosuppressive 
or biological agents can also be used to avoid 
chronic sequelae of the disease.
BEHCET’S DISEASE
Behçet’s Disease (BD) can be defined as 
a systemic vasculitis that usually affects 
venules, sometimes veins, rarely arterioles 
and exceptionally arteries. These different 
frequencies remain unexplained as yet. The 
eye is the most commonly involved organ, with 
typical manifestations of relapsing-remitting 
panuveitis and retinal vasculitis. As a systemic 
disease, BD may also affect the CNS.
Neuro-Behçet (N-BD) shows ethnic 
variations and also disparity within the same 
ethnic group and from one study to another; this 
depends on inclusion criteria and characteristics 
employed in each study. The following 
illustrates this variability. In a group of 558 
Figure 9. Neuro-sarcoidosis: multiple granulomas in 
the white matter of both brain hemispheres (contrast 
enhanced T1-weighted MRI image). Focal parenchymal 
lesions are T2-hyperintense and T1-isointense (with 
homogeneous contrast enhancement, as in this figure).
Figure 10. Neuro-sarcoidosis (T1 MRI sequence): homo-
geneous contrast enhancement of the leptomeninges and 
of a granuloma located in the posterior fossa.CNS Diseases and Uveitis; Allegri et al
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Turkish BD subjects Akman-Demir49 detected a 
29% of N-BD patients among which, 38 patients 
(6.8%) with angio-Behçet were found; another 
Turkish author, Kural-Seyahi50 showed that 
N-BD affects males (13%) more than females 
(5.6%); Hamdan51 demonstrated that among 
90 Lebanese subjects, 20 (23%) suffered from 
it and 2 (2.2%) had angio-Behçet; Benamour52 
found a 16.6% of N-BD subjects in a group 
of 925 Moroccan patients. B’chir Hamzaoui53 
pointed out that 11.6%of cases among 519 
BD Tunisian patients had CNS involvement; 
Borhani-Haghighi54 in a previous smaller 
epidemiological statistic, found 8.7% of N-BD 
patients but in a wider statistic (690 patients) 
found only 2.6%.
The frequency of BD neurological 
manifestations varies from 3% to 30% and 
seems to be high among Arabs, intermediate 
in Turkish subjects and low in Japanese 
individuals.55 Neurological or gastroenteric 
onset of BD is considered a negative prognostic 
factor. According to the type of affected vessels, 
N-BD displays various manifestations: 49,54,56–64 
a)   If small veins are involved, the condition 
corresponds to the meningo-parenchymatous 
form (MP). 
b)   If veins are affected, the term angio- BD 
is employed.
c)   If small arteries (vasa vasorum) are involved, 
aneurysms may rarely develop.
MP is the prevalent form and the MP/
angio-BD ratio varies from 3/1 to 11/1 
according to different statistics. Male subjects 
are more frequently affected by BD and N-BD. 
The pathogenesis of MP and angio-BD is an 
unsolved problem; we only know that the two 
forms have different pathogenic mechanisms, 
in fact they rarely appear in the same patient.
MP shows tropism for the brainstem in 
which the venous circle appears to have slower 
blood flow than other districts; however, only 
the mesencephalon and pons are involved 
whereas the bulbus remains undamaged. Other 
preferred CNS structures are the cerebellum, 
basal ganglia, internal capsule and meninges.
The course of MP is very similar to MS, 
with relapsing-remitting primary and secondary 
chronic-progressive forms; the only difference 
is in the sudden onset of symptoms and the 
lower frequency of MP relapses. As a relapse 
symptom, headaches are very frequent, are 
mostly hemicranial (with or without aura) 
rather than meningeal, and are related to 
lesions in the periaqueductal grey matter (a 
pontine structure involved in the pathogenesis 
of migraine).
Bilateral pyramidal signs are the most 
common symptoms of MP; other symptoms 
include behavioral disorders (at onset, 
personality regression; later, cognitive 
impairment, subcortical dementia and 
psychiatric manifestations) and less frequently 
brainstem signs, e.g. several forms of 
ophthalmoplegia (not only the internuclear 
kind, as in MS). Meningeal symptoms are rare 
despite the specific “meningo-parenchymatous” 
involvement, optic neuritis is also rare.
Intracranial hypertension is the main 
presentation of angio-BD and is due to 
thrombosis of venous sinuses (sinus sagittalis 
superior and sinus transversus) where flow 
is low. Intracranial hypertension gives rise to 
papilledema and often abducens palsy from 
extrinsic compression. Headaches are very 
frequent in the acute phase and are sometimes 
associated with fever.
When compared to MP, angio-BD shows an 
earlier outbreak, an invariably acute course (it 
is never chronic-progressive), a better response 
to therapy and a more favorable prognosis.
Rare forms of N-BD are: aneurysms, 
indirectly caused by vasa vasorum vasculitis 
and by sectorial arterial wall ischemia (the 
encephalic circle is infrequently compromised 
but the abdominal aorta and iliac arteries are 
frequently affected); pseudotumor (mimicking a 
neoplasm on neuro-radiological investigations), 
characterised by bulky localisation of the MP 
form; different types of neuropathies (from 
vasa nervorum vasculitis; the presence of 
electrophysiologic axonal-type alterations, as 
in ischemic neuropathies, has been reported 
in patients without neuropathic symptoms65).
From an ophthalmological point of view66,67, 
the eye may show different lesions ranging 
from severe non-granulomatous anterior 
uveitis with sterile hypopyon to vitritis, CNS Diseases and Uveitis; Allegri et al
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ischemic necrotizing retinitis or occlusive 
retinal vasculitis. Fluorescein angiography 
(FA) is the most useful imaging modality 
used for assessment of inflammatory and 
occlusive involvement of retinal vasculature 
and for detection of complications such as 
pre-retinal neovascularization. Color Doppler 
ultrasonography shows orbital and ocular 
hemodynamic alterations.
Major diagnostic techniques for BD are 
CSF analysis which shows blood-brain-barrier 
damage, pleocytosis, and sometimes oligoclonal 
bands; MRI which shows different patterns in 
the MP subtype according to the stage of the 
disease. In early stages, the lesions are T1-
isointense and T2-hypointense; in subacute and 
late stages, the same lesions are both T1- and 
T2-hyperintense (Figures 11A, 11B and 12). 
Flow absence corresponding to the presence of 
a thrombus is seen in angio-BD. VEPs are often 
abnormal, despite the rarity of optic neuritis, 
with a peculiar pattern which shows a very 
small amplitude in the acute stage without 
increased latency (unlike MS). Single photon 
emission computed tomography (SPECT) is 
positive, although many cases do not show 
neurological signs demonstrating early cerebral 
involvement.
Recently, Turkish authors reported that 
in patients with BD uveitis, treatment with 
oral cyclosporine seems to be associated with 
Figure 12. Behçet ‘s disease, meningo-parenchymatous 
form: wide truncal signal alterations (mostly T2-
hyperintense, with some T2-hypointense foci).
Figure 11 (A-B). Behçet‘s disease, meningo-parenchy-
matous form: pontine lesions on axial (A) and coronal 
(B) T2-weighted MRI images.
A
BCNS Diseases and Uveitis; Allegri et al
300 JOURNAL OF OPHTHALMIC AND VISION RESEARCH 2011; Vol. 6, No. 4
an increased risk of MP forms, although the 
reason is unknown.67
VOGT-KOYANAGI-HARADA DISEASE
Vogt-Koyanagi-Harada (VKH) disease is one of 
the most common uveitic-related neurological 
diseases. This condition affects other 
apparently heterogeneous tissues including 
the leptomeninges, cochlea and skin which are 
similar in the presence of melanocytes. In fact, 
during embryogenesis, most pigment cells arise 
from cranial or truncal portion of the neural 
crest and migrate to the skin, hair bulbs, choroid, 
inner ear, leptomeninges and other tissues.68 
VKH syndrome is an autoimmune disease 
which “targets” three enzymes involved in the 
synthesis of melanin: tyrosinase and two other 
related enzymes, namely tyrosinase-related 
protein (TRP) 1 and 2. Other target proteins 
also probably have a pathogenic role (MART-
1, PMel-17/gp100, KU-MEL-1, PAX-3)69. This 
“overabundance” of auto-antigens supports 
the “antigen unmasking” hypothesis, probably 
triggered by a virus such as EBV, which explains 
direct tissue damage leading to the release and 
unmasking of segregated substances.
VKH is related to HLA-DR4 ad HLA-DR53 
which are predominant in some ethnic groups 
(Japanese, Chinese, North-American and 
Hispanic) and to the HLA-DRB 1*0405 allele, 
which is predominant in Brazilians 69,70.
The incidence of neuro-otologic symptoms 
is related to ethnicity. Meningism and the CSF 
pattern of monocytic meningitis are prevalent 
in the Japanese. Otological symptoms and 
perceptive deafness are more frequent in the 
Japanese, whereas tinnitus shows a similar 
distribution in all studied populations apart 
from Hispanic populations who are less affected 
by otological symptoms. Hearing involvement 
can persist over many years.
The meninges are affected in the prodromal 
stage which is characterized by fever, headache, 
neck stiffness and psychomotor retardation 
together with cochlear involvement which 
causes dysacusis and tinnitus. Neuro-otologic 
symptoms are more prominent in the second 
stage, when uveitis also occurs (i.e. the acute 
uveitic or uveitic-acoustic stage). Vestibular 
symptoms are rare, probably because different 
types of melanocytes are present in the inner 
ear. The skin is involved in the third stage, 
i.e. the convalescent stage, when “sunset glow 
fundus” and retinal pigmentary abnormalities 
can occur. In the fourth stage, if the disease is 
untreated, ocular complications can appear.71,72
Ocular Manifestations
In the acute stage, fundus findings consist of 
bilateral multifocal serous retinal detachments 
in the posterior pole together with optic 
nerve inflammatory edema. FA reveals retinal 
pigment epithelium (RPE) hyperfluorescent 
dots, multiple round areas of dye pooling in 
the subretinal space, and optic disc leakage. 
Indocyanine green angiography (ICGA) 
demonstrates patchy filling delay of choroidal 
vessels and the choriocapillaris, diffuse dye 
leakage, and multiple hypofluorescent spots. 
Optical coherence tomography (OCT) shows 
large serous retinal detachments in the central 
area.
In the convalescent stage, fundus exam-
ination reveals the typical sunset-glow 
appearance with irregular linear pigmentation 
in the posterior pole. FA shows granular 
hyperfluorescence reflecting RPE damage and 
ICGA demonstrates significant improvement 
in filling delay, but hypofluorescent dark 
spots (choroidal granulomas) persist for a long 
period.71-80
Neurologic Manifestations
In early stages, neurological manifestations 
appear before ocular symptoms. Main symptoms 
are fever, headache, nausea, photophobia, 
meningism and neck stiffness, orbital pain 
(related to optic nerve edema or hyperemia) 
and galea capitis hyperesthesia. A recent study 
identified anterior ischemic optic neuropathy 
(AION) with irreversible visual field defects 
(6 cases in 52 consecutive patients).75 
CSF examination allows early diagnosis by 
showing a not very high monocytic pleocytosis 
(about 400/mm3) causing confusion with an CNS Diseases and Uveitis; Allegri et al
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infectious process. A recent review by Andreoli 
and Foster72 showed that CSF specimen was 
positive in more than 80% of cases in the first 
week, and in 97% of cases three weeks after 
the onset of symptoms. CSF changes have 
been reported in patients with no neurological 
symptoms.76,77 Lymphocytic pleocytosis, hyper-
proteinorrachia, and macrophages with melanin 
depots are other CSF findings.
Monocytic pleocytosis can persist for 
a long time but usually remits after eight 
weeks or much later. A correlation between 
pleocytosis and “sunset glow fundus” in the 
convalescent stage was reported by Keino77; 
in fact, significant neurologic inflammation 
at the onset will predict the development of 
long term VKH complications. According to 
Touitou76, a correct diagnosis of VKH is made 
with the combination of international diagnostic 
criteria74 together with 1) clinical examination, 
2) CSF examination (pleocytosis) and 3) FA-
OCT demonstrating serous detachment in 
the posterior pole (present in over 98% of 
cases). However the most efficient tool for 
early diagnosis and subsequent monitoring 
of subclinical choroidal disease is ICGA.78,79 
If choroidal disease is followed and treated 
using ICGA, chronicity and complications may 
be avoided.80
ACUTE POSTERIOR MULTIFOCAL 
PLACOID PIGMENT EPITHELIOPATHY 
Acute posterior multifocal placoid pigment 
epitheliopathy (APMPPE) is a primary 
inflammatory choriocapillaropathy often 
provoked or preceded by a viral infection. 
The condition may present with neurological 
symptoms which are variable or can follow 
ocular manifestations. Typical ocular symptoms 
are photopsia, scotoma and visual loss. Ocular 
findings include deep bilateral areas of yellowish 
discoloration in the posterior pole with multiple 
serous exudative retinal detachments, together 
with mild vitritis and anterior uveitis. ICGA 
shows round geographic hypofluorescent areas 
which represent choriocapillaris non-perfusion 
(Fig. 13).
The most frequent neurological symptoms 
is meningism with lymphocytic pleocytosis 
and headaches.80,81 Less frequently, ischemic 
strokes due to cerebral vasculitis causing 
focal deficits, mainly involving the posterior 
circulation (with visual field defects) and the 
basal ganglia may occur. These strokes arise 
simultaneously or even before ocular symptoms. 
Another relatively rare symptom is transient 
hearing loss. All of these signs and symptoms 
lead to the suspicion that APMPPE might be 
a peculiar form of VKH disease.
APMPPE must be suspected in a young 
(20 to 30 year old) patient with a viral flu-like 
syndrome, stroke of unclear etiology, meningism 
with CSF pleocytosis, and ocular symptoms 
such as photopsia, scotoma and visual blurring.
OTHER RARE INFLAMMATORY DISEASES
Kawasaki’s disease or the “mucocutaneous 
lymph node syndrome” can present as a 
bilateral anterior uveitis with or without 
aseptic meningitis and monocytic pleocytosis 
in children and young adults.
Crohn’s disease and ulcerative colitis 
can cause ocular signs including iritis, 
conjunctivitis, episcleritis, scleritis and uveitis; 
and inflammatory/ischemic neurological 
symptoms i.e. optic neuritis and other cranial 
nerve neuropathies, especially oculomotor 
nerves.
Cogan’s syndrome consists of acute 
interstitial keratitis and vestibulo-auditory 
dysfunction. The latter deficit may also occur 
in Eale’s disease, which is very frequent in 
India; the main sign is retinal periphlebitis 
without true uveitis.
Relapsing polychondritis is an autoimmune 
Figure 13. Acute posterior multifocal placoid pigment 
epitheliopathy (APMPPE). Multiple bilateral confluent 
yellowish fundus lesions corresponding to choriocapillaris 
nonperfusion on ICGA (right frame).CNS Diseases and Uveitis; Allegri et al
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disease targeting type II collagen characterized 
by destructive and relapsing inflammation 
of the cartilage in organs such as the nose, 
earlobe and trachea. Ocular manifestations 
include episcleritis, scleritis and iridocyclitis; 
neurological symptoms are encephalic 
(confusional states, epilepsy and stroke). 
Cranial nerves, chiefly the optic nerve and 
sensorineural deafness, are involved in 
necrotizing vasculitis 15.
Susac’s syndrome (retino-cochleo-cerebro 
vasculopathy) is a very rare immune-
mediated microangiopathy characterized 
by encephalopathy, branch retinal arterial 
occlusion (BRAO) and hearing loss of unknown 
etiology. The main presenting symptoms are 
CNS features.82
Presenting symptoms of encephalitis are 
personality and behavioral changes, associated 
with intense headaches and migraine. MRI 
shows small multifocal supra-tentorial lesions 
(especially in the corpus callosum) mainly 
involving the white matter, however, the grey 
matter is sometimes affected as well.
Visual symptoms are related to the site of 
occlusion: if in the retinal periphery (and also 
in encephalopathic or otherwise uncooperative 
patients) there are no visual complaints; if it 
involves the central area, the affected subject 
may complain of visual impairment which is 
usually bilateral and may sometimes be the 
presenting symptom. Branch retinal artery 
occusion may be extensive or limited and 
FA is the main imaging technique to show it; 
after resolution silver streaks are noted which 
replace the occluded arterioles. Cerebral and 
visual symptoms are joined to some hearing 
loss forms.83
Differential diagnoses include MS and 
ADEM (acute disseminated encephalo-myelitis). 
The differentiating feature on MRI is that the 
lesions related to the two latter conditions are 
located inside the undersurface of the corpus 
callosum and not in the central area as in Susac’s 
syndrome.84 Furthermore; leptomeningeal 
involvement is very rare with MS and ADEM. 
ADEM frequently involves the deep grey matter.
Susac’s syndrome has a self-limiting but 
long and fluctuating course, ranging from one to 
five years with tendency towards spontaneous 
improvement. 
Although the etiology is unknown, findings 
from brain biopsies suggest small vessel 
occlusive vasculitis caused by an autoimmune, 
viral-mediated or hypercoagulability disease. In 
this way, ocular, brain and cochlear arteriolar 
micro-vascular occlusion are explained.85
No treatment is evidence-based because the 
disease is very rare. However, high doses of 
intravenous steroids and immuno-suppressive 
agents are considered to be the mainstay of 
therapy.
LYMPHOMAS
The eye can be involved in both systemic and 
diffused hemoblastomas, particularly in B 
small-cell non-Hodgkin lymphoma (NHL), and 
in a specific form of lymphoma, primary CNS 
lymphoma (PCNSL) which is more appropriately 
defined as CNS and ocular lymphoma i.e. a 
single neoplastic manifestation that can be 
localized to the CNS, the eye, or both. 
PCNSL represents 4-6% of all cases 
of primary CNS lymphomas and 1-2% of 
extranodal lymphomas.86 Its incidence was 
found to be 0.43 per 100.000 in a study by 
Küker.86 The number of new cases appears to 
have been increasing in the past fifteen years, 
probably due to the increase in AIDS and organ 
transplantation. These immuno-deficiencies, 
together with congenital types, are the three 
main risk factors for this disease. Female 
patients outnumber male subjects by a ratio 
of 2/1.88 The disease is prevalent in the fifth 
and sixth decades of life but rare in children 
and young people.
According to a an older report, ophthalmic 
localizations precede neurological ones89,90, 
however more recent surveys support the 
opposite. The reason may be improvements 
in diagnostic imaging.
When ocular symptoms (vitreous cells, 
exudative retinal detachment and multifocal 
creamy deep retinal masses) occur prior to 
neuro-radiologic manifestations, the disease 
is designated primary intraocular lymphoma 
(PIOL). Infrequently, lymphoma is localized to CNS Diseases and Uveitis; Allegri et al
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the eye or the brain, probably due to diagnostic 
inaccuracy.
Typically, in a female patient older 
than fifty, chronic uveitis without a well-
defined etiology which lacks classic signs of 
anterior segment (synechiae, pain) or retinal 
inflammation (vasculitis) and is unresponsive 
to steroids, should raise the suspicion of 
lymphoma. Certain infectious agents including 
HSV-8, EBV and toxoplasma gondii have been 
suggested in the pathogenesis of this condition 
by stimulating B lymphocytes to evolve into 
lymphomatous cells.13,91-93
The two main pathogenic hypotheses93 are 
1) transformation of a benign inflammatory 
process in the eye or the CNS into a neoplasm 
via monoclonal B-lymphocyte proliferation and 
2) metastasis of an “occult” systemic lymphoma, 
eradicated from other body structures by a 
competent immune system to the CNS and eye 
because of their immunologically “privileged” 
characteristics. The latter suspicion is supported 
by positron emission tomography studies, 
suggesting that systemic lymphoma is present 
in individuals who are negative on both whole 
body CT scan and bone marrow biopsy.94 Many 
studies85,94 confirm that PCNSL is a large B-cell 
lymphoma (about 95% of all the studied cases).
From an immunogenetic point of view, the 
majority (60–75%) of PCNSL cases demonstrate 
a deletion95 on the long arm of chromosome 
6 which contains a lymphoma-suppressor 
gene, perhaps the PTPRK gene involved in 
the regulation of lymphocyte contact and 
adherence94. This deletion does not occur in 
systemic lymphomas and is useful to determine 
the prognosis, which is more unfavourable in 
PCNSL.
In cerebral PCNSL, the lesions are usually 
supratentorial, multicentric and localized 
in the basal ganglia, corpus callosum and 
periventricular areas with a predilection for 
the frontal lobe.90 The variety of localizations 
corresponds to the range of neurological 
symptoms. Since encephalic lesions are deep-
seated, epilepsy is relatively rare in contrast 
to other cerebral malignancies.89,96
The prevalence of frontal lobe involvement 
corresponds to personality and sleep 
disorders86,89,96. Age and severity of functional 
damage are major prognostic criteria. Meningeal 
symptoms indicate an even more unfavourable 
prognosis. 
Ocular localization is rare but is the most 
common malignancy causing a “masquerade” 
syndrome. PIOL is a diffuse large B-cell 
lymphoma97 presenting with floaters, photopsia 
and blurred vision. It usually is unilateral at 
onset but becomes bilateral within one year. The 
typical finding is a peculiar infiltrative but not 
inflammatory vitritis. Lymphomatous keratic 
precipitates may also be seen on the corneal 
endothelium. FA shows RPE abnormalities, such 
as round hypo- or hyperfluorescent defects, 
because PIOL cells lodge between the RPE and 
Bruch’s membrane, and clumps of them can be 
detected by OCT imaging. Vitreous or retinal 
biopsy can be useful in suspicious cases for 
histopathological and immunohistochemical 
characterization.
Another very useful diagnostic tool is the 
detection of interleukin-10 (IL-10) in the serum 
and aqueous humor produced by malignant 
B-cells98; IL-10 belongs to the Th2 cytokine 
group and acts as a “growth factor” for B-cells 
and therefore contributes to the development 
and proliferation of PCNSL by inhibiting Th1 
cytokines and consequently, T cell cytotoxic 
effects against malignant B-cells. Furthermore, 
it increases BCL-2 gene expression on B-cells 
and prevents their apoptosis. IL-10 is increased 
in PCNSL serum (similar to AIDS-associated 
lymphomas and EBV-related Hodgkin’s 
disease) and CSF. In the aqueous humor, an 
increased value (more than 1.0) of IL-10 and 
IL-10/IL-6 (a cytokine mainly produced by 
inflammatory cells) ratio is diagnostic for the 
presence of PIOL/PSNCL. In the serum, this 
ratio is related to both the clinical expression 
and the prognosis of the disease.
Eye and brain CT are usually sufficient to 
make a diagnosis of PCNSL but a specific CT 
or MRI pattern does not exist. Some features 
are frequently present89: a) CT-scans without 
contrast show isodense lesions which are more 
common (84%) than hyperdense lesions which 
only account for 16%; b) contrast enhanced 
CT-scans show persisting homogeneous CNS Diseases and Uveitis; Allegri et al
304 JOURNAL OF OPHTHALMIC AND VISION RESEARCH 2011; Vol. 6, No. 4
(94%), well-defined (83%) areas of contrast 
enhancement (Fig. 14).
Typically, lesions involve the corpus 
callosum, basal nuclei, or periventricular white 
matter91; they are spontaneously isodense (rarely 
hyperdense) and present with homogeneous 
contrast enhancement which is never annular, 
a feature in contrast to other tumor metastases. 
The “phantom tumor” is a name given to the 
“classic” disappearance of lesions after steroid 
therapy.
MRI without contrast shows PCNSL 
localizations as T1 hypointense and T2 
hyperintense patterns, similar to MS.91 MRI 
with contrast shows intense well-defined, 
rarely annular, areas of contrast enhancement 
(as on CT scan).96 A single localization can be 
mistaken for a stroke.
PARANEOPLASTIC SYNDROME
Paraneoplastic optic neuropathy (PON), has 
been described in cases of microcytic lung 
carcinoma and thymoma99, and presents 
with typical ocular symptoms, optic neuritis, 
retinitis, inflammatory vitritis and progressive 
loss of vision. Neurological signs are nonfocal 
encephalomyelopathy (with an inflammatory 
CSF), ophthalmoplegia and subacute cerebellar 
syndrome.100 This disease is caused by the 
presence of anti-CRMP-5 (collapsine responsive 
mediator protein–5) protein, which belongs to 
the semaphorine group i.e. proteins that play 
a role in the development of neuronal network 
in the CNS.
CONCLUSION
As highlighted in this review, a number of 
disorders with heterogeneous origins present 
with oculocerebral symptoms and signs, with 
onset sometimes in one or both organs. These 
syndromes may be difficult to manage because 
they are uncommon and difficult to diagnose. 
Treatment requires qualified interdisciplinary 
knowledge and management at specialized 
referral centers.
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